Apogee Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $13M | 320k | 39.73 |
| 2025-06-30 | $12M | 266k | 43.43 |
| 2025-03-31 | $10M | 272k | 37.36 |
| 2024-12-31 | $13M | 278k | 45.30 |
| 2024-09-30 | $17M | 280k | 58.74 |
| 2024-06-30 | $9.4M | 239k | 39.35 |
| 2024-03-31 | $16M | 241k | 66.45 |
| 2023-12-31 | $4.4M | 156k | 27.94 |
| 2023-09-30 | $3.2M | 151k | 21.30 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management